Atlas Trials

A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

Clinical trial NCT05432167 · COMPLETED

Trial details

NCT number
NCT05432167
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Uncontrolled HypertensionChronic Kidney Diseases
Start date
2022-04-29
Primary completion
2024-05-02
Enrollment
195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.